Advanced Biomed Inc. Common Stock (ADVB) vs InMed Pharmaceuticals Inc. (INM)
A side-by-side comparison of Advanced Biomed Inc. Common Stock and InMed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADVB
Advanced Biomed Inc. Common Stock
$6.60HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
INM
InMed Pharmaceuticals Inc.
$1.34HealthcareDelayed quote: Oct 6, 2026, 9:47 AM EDT
Total return — ADVB vs INM
growth of $100 · dividends reinvested · last 2yADVB -91.3% (-70.5%/yr)INM -49.8% (-29.2%/yr)INM compounded faster over this window
Log scale — wide-divergence pair
ADVB INM
ADVB vs INM: by the numbers
- •ADVB is the larger company ($9M vs $7M market cap).
- •Both run net losses; ADVB's is the smaller (0.00% vs -0.61% net margin).
Metrics side by side
Valuation
| Metric | ADVB | INM |
|---|---|---|
| P/S ratio | N/A | 0.00 |
| P/B ratio | 0.99 | 6.86 |
Profitability
| Metric | ADVB | INM |
|---|---|---|
| Gross margin | 0.00% | 14.92% |
| Operating margin | 0.00% | -0.52% |
| Net margin | 0.00% | -0.61% |
| ROE | -7.36% | -1168.44% |
| ROIC | -11.06% | -995.44% |
Growth (annualized)
| Metric | ADVB | INM |
|---|---|---|
| Total return CAGR (5Y) | N/A | -71.98% |
Go deeper
Dig into the metrics
Advanced Biomed Inc. Common Stock ROEInMed Pharmaceuticals ROEAdvanced Biomed Inc. Common Stock operating marginInMed Pharmaceuticals operating marginAdvanced Biomed Inc. Common Stock revenue growthInMed Pharmaceuticals revenue growthAdvanced Biomed Inc. Common Stock free cash flowInMed Pharmaceuticals free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.